LEO 80185 gel

DRUG3 trials

Sponsors

LEO Pharma

Conditions

Psoriasis Vulgaris

Phase 1

Dermatopharmacokinetic Trial of LEO 80185 Gel

CompletedNCT02605057

LEO PharmaPsoriasis Vulgaris

Start: 2015-11-30End: 2016-07-31Updated: 2025-02-24

Phase 2

An International, Multi-centre, Prospective, Non-controlled, Open, Single-group, 8-week Trial in Adolescent Subjects

CompletedNCT02038569

LEO PharmaPsoriasis Vulgaris

Start: 2014-01-31End: 2018-02-13Updated: 2025-03-10

Phase 3

LEO 80185 Gel (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Psoriasis

CompletedNCT02668692

LEO PharmaPsoriasis Vulgaris

Start: 2016-02-29End: 2016-06-30Updated: 2025-03-10